患者报告能否更早发现药物安全信号?全球数据库中患者与医务人员报告时间的回顾性比较
该研究基于世界卫生组织VigiBase数据库,回顾性比较患者与医务人员报告导致药物安全信号的药物-不良反应关联的时间差异。共纳入2822份报告,患者报告占52.7%。所有信号的中位检测时间为10.4年,医务人员报告早于患者(中位7.0年 vs 8.3年,P<0.001),提前1.3年。
要点
- 患者报告占最终形成信号的药物-不良反应报告的一半以上。
- 医务人员报告比患者报告提前1.3年(中位7.0年 vs 8.3年)。
- 患者报告对信号检测有价值,可鼓励患者更早报告疑似不良反应。
核心结论
- 患者对最终形成信号的药物-不良反应关联贡献了大部分报告,但医务人员报告比患者早1.3年。
- 研究结果强化了患者报告在信号检测中的价值,并提示可鼓励患者更早报告疑似不良反应。
研究设计与样本
- 回顾性比较研究,数据来自世界卫生组织VigiBase个例安全报告全球数据库。
- 选取导致药物安全信号的药物-不良反应关联报告,共纳入2822份报告。
- 以每个信号的首份报告日期为零点,计算报告日期与零点的时间差。
- 使用Mann-Whitney U检验分析生存曲线上的时间差异。
主要发现
- 共纳入2822份报告,其中52.7%为患者报告,所有纳入信号的中位患者报告比例为25%。
- 所有信号的中位检测时间为10.4年。
- 总体医务人员报告早于患者:中位7.0年 vs 8.3年(P<0.001)。
临床怎么用
- 临床药学智能体可向患者强调报告疑似不良反应的重要性,并鼓励尽早报告。
- 在信号检测中应整合患者报告数据,同时认识到医务人员报告可能更早。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To explore if there is a difference between patients and healthcare professionals (HCPs) in time to reporting drug-adverse drug reaction (ADR) associations that led to drug safety signals. METHODS: This was a retrospective comparison of time to reporting selected drug-ADR associations which led to drug safety signals between patients and HCPs. ADR reports were selected from the World Health Organization Global database of individual case safety reports, VigiBase. Reports were selected based on drug-ADR associations of actual drug safety signals. Primary outcome was the difference in time to reporting between patients and HCPs. The date of the first report for each individual signal was used as time zero. The difference in time between the date of the reports and time zero was calculated. Statistical differences in timing were analysed on the corresponding survival curves using a Mann-Whitney U test. RESULTS: In total, 2822 reports were included, of which 52.7% were patient reports, with a median of 25% for all included signals. For all signals, median time to signal detection was 10.4 years. Overall, HCPs reported earlier than patients: median 7.0 vs. 8.3 years (P < 0.001). CONCLUSIONS: Patients contributed a large proportion of reports on drug-ADR pairs that eventually became signals. HCPs reported 1.3 year earlier than patients. These findings strengthen the evidence on the value of patient reporting in signal detection and highlight an opportunity to encourage patients to report suspected ADRs even earlier in the future.
引用
- Rolfes L, van Hunsel F, Caster O, et al. Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database. Br J Clin Pharmacol. 2018. PMID: 29522255. doi:10.1111/bcp.13576
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。